Trius Therapeutics

Trius Therapeutics is focused on the development of innovative antibiotics for life-threatening infections.
  • Industry: Biopharma
  • Website: http://triusrx.com/
  • Facebook: https://www.facebook.com/merckbewell
  • Twitter: https://www.twitter.com/cubistbiopharma
  • Location: Lexington, MA
  • Size: 501-1,000 employees
  • Overview: Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.

Search 1.5 billion
Email & Phone#

Browse to anyone's Linkedin profile, and Contactout will find that person's email address and phone number

Start your free trial
(300+ Reviews)

People also viewed these companies

  • Marketing and Advertising
  • Nonprofit Organization Management
  • E-Learning
  • Management Consulting
  • Industrial Automation
  • Computer Software
  • Environmental Services
  • Real Estate